Navigation Links
Pharma Medical Science Liaison Outreach Shifting Away from Traditional Company Sales Regions
Date:8/22/2011

CHAPEL HILL, N.C., Aug. 22, 2011 /PRNewswire/ -- With the support of Key Opinion Leaders clearly linked to success in the marketplace, competition for the time and attention of KOLs is intensifying. But the changing regulatory and access environment has altered the landscape for creating and maintaining KOL and physician relationships.

To help biopharma organizations navigate this new KOL landscape, Best Practices, LLC has published an updated MSL-focused report that highlights the optimal size, mix and service frequencies of these elite medical specialists.

The 78-page report, "Medical Science Liaisons: Gaining Access and Forging Relationships with Key Opinion Leaders (Updated for 2011)," presents 2011 data compared to data gathered in 2009 on an array of critical questions that provide insights into how MSLs can build strong, productive relationships with KOLs and physicians.

One of the emerging trends in 2011 involves a change in how MSLs are deployed in the field.  According to the study:

  • Benchmarked companies appear to have shifted away from aligning MSLs to reflect a sales region or geographic distribution. Companies have moved towards deploying based on the concentration of KOLs in a given area; 79% of companies deploy along this model.

With interviews and key insights drawn from 27 leaders at 24 leading bio-pharmaceutical companies, this Best Practices, LLC benchmarking study identifies a wealth of strategies and proven tactics that helps Medical Affairs and other executives to effectively determine the optimal number of liaisons, mix of responsibilities, number of interactions and span of control that are critical to build strong and productive relationships over the life of a brand.

The full 78-page report contains more than 600 benchmark metrics and scores of executive narratives that companies can use to benchmark key management factors reflecting size, service levels and roles of Medical Science Liaisons in serving KOLs and hard-to-see physicians.

Key topics of this primary research include:

  • Benchmark pre and post-launch service activities
  • Identify drivers of group size & focus
  • Gain insight into structuring & aligning medical with sales organizations
  • Identify optimal call frequencies and service levels with thought leaders
  • Budget allocation to MSL function  

To learn more about the study, download a complimentary summary at http://www.best-in-class.com/rr1107.htm.

For more information, contact Cameron Tew, Executive Director of Research and Publishing at Best Practices, LLC at (919) 767-9246 or ctew@best-in-class.com.

BEST PRACTICES, LLC conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for more than 17 years; our clients include 48 of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President
2. CVS Caremark Appoints Mark S. Cosby as President of CVS/pharmacy
3. Specialty Pharma Association Announces Fall Conference
4. Enox Biopharma, Inc. Will Be Granted its Foundation Patent
5. Spaulding Clinical Announces Strategic Partnership with Clinigene International, India for Providing Comprehensive Early Clinical Solutions to Pharmaceutical and Biotech Clients
6. Food and Drug Administration (FDA) Joins Pharma IQs Viral Safety 2011 Conference
7. Valeant Pharmaceuticals Completes Acquisition of Sanitas Group
8. Pharmaceutics International, Inc. (Pii) Successfully Completes EMA and FDA Inspection
9. NY Top Drugstore Lobbyist Admits Mail-Service Pharmacy Saves Money... But Pushes Gov. Cuomo to Sign a Bill to Stop Employers From Using it
10. CoLucid Pharmaceuticals Receives Clearance for Investigational New Drug (IND) Application for Lasmiditan for the Treatment of Acute Migraine
11. Valeant Pharmaceuticals Announces Resignation of Michael Van Every From Valeants Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
Breaking Medicine Technology:
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
Breaking Medicine News(10 mins):